SCHEMBL7296016

SCHEMBL7296016

OC1(Cc2ccc(F)cc2F)CCNCC1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GRIN2B Q13224 4/20 0.42
HTR2A P28223 1/20 0.40
SLC6A2 P23975 2/20 0.40
SLC6A4 P31645 2/20 0.40
SLC6A3 Q01959 2/20 0.40
TRPA1 O75762 1/20 0.39
IDO1 P14902 2/20 0.39
AGXT P21549 2/20 0.39
KDM4E B2RXH2 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
HTR2C P28335 2/20 0.36
FPR2 P25090 1/20 0.36
PROKR1 Q8TCW9 1/20 0.36
DPP4 P27487 1/20 0.36
HTR6 P50406 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL14840535 0.98 GRIN2B (0.41) GRIN2BHTR2ASLC6A2SLC6A4SLC6A3
SCHEMBL16657600 0.84 PROKR1 (0.49) HTR2ASLC6A2SLC6A4SLC6A3HTR2C
SCHEMBL28240932 0.83 GRIN2B (0.43) GRIN2BHTR2ASLC6A2SLC6A4SLC6A3
SCHEMBL26081071 0.83 KDM4E (0.47) GRIN2BHTR2ASLC6A4SLC6A3TRPA1
SCHEMBL26081070 0.82 SLC6A2 (0.41) HTR2ASLC6A2SLC6A4SLC6A3TRPA1
SCHEMBL19030449 0.81 GRIN2B (0.42) GRIN2BHTR2ATRPA1IDO1AGXT
SCHEMBL376860 0.80 GRIN2B (0.40) GRIN2BSLC6A2SLC6A4SLC6A3IDO1
Hydrochloric Acid SCHEMBL20138412 0.79 GRIN2B (0.39) GRIN2BSLC6A2SLC6A4SLC6A3IDO1
SCHEMBL22719277 0.77 PROKR1 (0.39) HTR2ASLC6A2SLC6A4SLC6A3IDO1
SCHEMBL1574254 0.76 SLC6A2 (0.41) GRIN2BSLC6A2SLC6A4SLC6A3TRPA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017108723-A2 PYRAZOLO[1,5a]PYRIMIDINE DERIVATIVES AS IRAK4 MODULATORS F. HOFFMANN-LA ROCHE AG (CH) 2017-06-29 WO disclosed
US-6359138-B1 CENTRAL NERVOUS SYSTEM DISORDERS HOFFMANN-LA ROCHE INC. 2002-03-19 US disclosed
EP-0846683-B1 4-Hydroxy-piperidine derivatives HOFFMANN LA ROCHE (CH) 2001-09-19 EP disclosed
EP-0846683-A1 4-Hydroxy-piperidine derivatives F. HOFFMANN-LA ROCHE AG (CH) 1998-06-10 EP disclosed